Arkolith/Insider Trading/CYCN/Form 4

McGuire Terrance

DirectorCyclerion Therapeutics, Inc. (CYCN) · full profile →Form 4 · filed Jun 7, 2021
Net Buying
Open-Market Buys
$300K
Open-Market Sells
$0
Net Open-Market Flow
$300K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 3, 2021Buy(P)93K$3.12$290K697K
Jun 3, 2021Buy(P)3K$3.12$10K25K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-022327) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML